Evidence map›Paper›PMID 27071102›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Mapping physiological G protein-coupled receptor signaling pathways reveals a role for receptor phosphorylation in airway contraction.

Sophie J Bradley, Coen H Wiegman, Max Maza Iglesias, Kok Choi Kong, Adrian J Butcher, Bianca Plouffe, Eugénie Goupil, Julie-Myrtille Bourgognon, Timothy Macedo-Hatch, Christian LeGouill and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. GRespiratory research · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. PD 102807 Induces M3 mAChR-Dependent GRK-/Arrestin-Biased Signaling in Airway Smooth Muscle Cells.American journal of respiratory cell and molecular biology · 2022
    Article
  8. G protein-biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer's disease mouse model.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Article
  11. Article
  12. Targeting G protein-coupled receptor kinases (GRKs) to G protein-coupled receptors.Current opinion in endocrine and metabolic research · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Updates in the function and regulation of αBritish journal of pharmacology · 2019
    Review
  17. Article
  18. Review
  19. Article
  20. GαBritish journal of pharmacology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Sophie J BradleyMedical Research Council Toxicology Unit, University of Leicester, Leicester LE1 9HN, United Kingdom; Institute of Molecular Cell and Systems Biology, University of Glasgow, Glasgow G12 8QQ, United Kingdom;
Coen H WiegmanAirway Disease Section, National Heart & Lung Institute, Imperial College London, London SW3 6LY, United Kingdom;ORCID http://orcid.org/0000-0001-9161-0581
Max Maza IglesiasDepartment of Infection, Immunity, and Inflammation, Maurice Shock Medical Sciences Building, University of Leicester, Leicester LE1 9HN, United Kingdom;
Kok Choi KongSchool of Health Sciences, University of Brighton, Brighton BN2 4GL, United Kingdom;
Adrian J ButcherMedical Research Council Toxicology Unit, University of Leicester, Leicester LE1 9HN, United Kingdom; Institute of Molecular Cell and Systems Biology, University of Glasgow, Glasgow G12 8QQ, United Kingdom;
Bianca PlouffeInstitute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, QC, Canada H3C 3J7;
Eugénie GoupilDepartment of Medicine, McGill University, Montreal, QC, Canada H3A 2B2;
Julie-Myrtille BourgognonMedical Research Council Toxicology Unit, University of Leicester, Leicester LE1 9HN, United Kingdom;
Timothy Macedo-HatchMedical Research Council Toxicology Unit, University of Leicester, Leicester LE1 9HN, United Kingdom;
Christian LeGouillInstitute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, QC, Canada H3C 3J7;
Kirsty RussellAirway Disease Section, National Heart & Lung Institute, Imperial College London, London SW3 6LY, United Kingdom;
Stéphane A LaporteDepartment of Medicine, McGill University, Montreal, QC, Canada H3A 2B2;
Gabriele M KönigDepartment of Pharmacy, University of Bonn, 53115 Bonn, Germany.
Evi KostenisDepartment of Pharmacy, University of Bonn, 53115 Bonn, Germany.
Michel BouvierInstitute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, QC, Canada H3C 3J7;
Kian Fan ChungAirway Disease Section, National Heart & Lung Institute, Imperial College London, London SW3 6LY, United Kingdom;
Yassine AmraniDepartment of Infection, Immunity, and Inflammation, Maurice Shock Medical Sciences Building, University of Leicester, Leicester LE1 9HN, United Kingdom; ya26@le.ac.uk tba@le.ac.uk.
Andrew B TobinMedical Research Council Toxicology Unit, University of Leicester, Leicester LE1 9HN, United Kingdom; Institute of Molecular Cell and Systems Biology, University of Glasgow, Glasgow G12 8QQ, United Kingdom; ya26@le.ac.uk tba@le.ac.uk.
University of Leicester · GBImperial College London · GBInstitute for Research in Immunology and Cancer · CAMcGill University · CAUniversity of Bonn · DEUniversity of Brighton · GB

Funding

Canadian Institutes of Health Research 10501Medical Research Council
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) are known to initiate a plethora of signaling pathways in vitro. However, it is unclear which of these pathways are engaged to mediate physiological responses. Here, we examine the distinct roles of Gq/11-dependent signaling and receptor phosphorylation-dependent signaling in bronchial airway contraction and lung function regulated through the M3-muscarinic acetylcholine receptor (M3-mAChR). By using a genetically engineered mouse expressing a G protein-biased M3-mAChR mutant, we reveal the first evidence, to our knowledge, of a role for M3-mAChR phosphorylation in bronchial smooth muscle contraction in health and in a disease state with relevance to human asthma. Furthermore, this mouse model can be used to distinguish the physiological responses that are regulated by M3-mAChR phosphorylation (which include control of lung function) from those responses that are downstream of G protein signaling. In this way, we present an approach by which to predict the physiological/therapeutic outcome of M3-mAChR-biased ligands with important implications for drug discovery.

Indexed as

AnimalsBronchiHumansMiceMice, KnockoutMuscle, SmoothPhosphorylationReceptor, Muscarinic M3Signal TransductionReceptor, Muscarinic M3asthmaG protein-coupled receptorligand biasmuscarinicsignaling

Identifiers

PMID27071102
PMCPMC4843461
OpenAlexW2334275131

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.